Document is current
Any future updates will be listed below
-
Authors
Giao, Duc M.
Giugliano, Robert P. https://orcid.org/0000-0003-4110-7675
- License Information
-
More Information
Article History
Received: 7 September 2024
Accepted: 10 April 2025
First Online: 9 May 2025
Declarations
:
: Robert P. Giugliano is a member of the TIMI Study Group of the Brigham and Women’s Hospital, which has received research grants to support clinical trials from Amgen, Anthos Therapeutics, Daiichi Sankyo, and Ionis; and has received honoraria for CME program, lectures and/or consulting from Amgen, Artivion, Beckman Coulter, Daiichi Sankyo, Dr. Reddy’s Laboratories, Gilead, Inari, Inventiva, Medical Education Resources, Menarini, PhaseBio, SAJA Pharmaceutics, Samsung, Sanofi Aventis, Servier, and Summeet. Robert P Giugliano was previously an Editor-in-Chief of Cardiology and Therapy. Robert P Giugliano was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Duc M. Giao has no disclosures.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
